Spyre Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock
Hand-out
Press Releases
Spyre Therapeutics, Inc.  
November 19, 2024

Spyre Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock

WALTHAM, Mass., Nov. 18, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. ("Spyre" or the "Company") (NASDAQ: SYRE), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine

avatar profile Olean Times Herald

Olean Times Herald


Local & Social